F. Swan

发表

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.

W. Velasquez, P. Mclaughlin, F. Cabanillas, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cyclosporin plus doxorubicin, vincristine and etoposide in the treatment of refractory non-Hodgkin's lymphoma: a phase II study.

D. Moore, F. Cabanillas, A. Sarris, 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).

Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma.

P. Mclaughlin, L. North, F. Cabanillas, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin's disease.

W. Velasquez, L. Fuller, P. Mclaughlin, 1992, International journal of radiation oncology, biology, physics.

Prognostic value of serum beta-2 microglobulin in low-grade lymphoma.

S. Tucker, W. Velasquez, P. Mclaughlin, 1991, Annals of internal medicine.

No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion schedule.

P. Mclaughlin, F. Cabanillas, A. Younes, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.

P. Mclaughlin, F. Cabanillas, F. Cabanillas, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hodgkin's disease: study of treatment intensities and incidences of second malignancies.

S. Zimmerman, M. Munsell, W. Velasquez, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Immunotyping of lymphoma by fine-needle aspiration. A comparative study of cytospin preparations and flow cytometry.

E. Atkinson, N. Ordóñez, R. Katz, 1994, American journal of clinical pathology.

Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement.

P. Mclaughlin, F. Cabanillas, A. Sarris, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

NOVP and radiotherapy for early-staged Hodgkin's disease: an interim analysis.

L. Fuller, P. Mclaughlin, F. Cabanillas, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

High-dose combination chemotherapy with cyclophosphamide, carmustine, etoposide, and autologous bone marrow transplantation in 60 patients with relapsed Hodgkin's disease: the M. D. Anderson experience.

S. Jagannath, F. Cabanillas, J. Spinolo, 1989, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

High dose cyclophosphamide, BCNU, and VP‐16 (CBV) as a conditioning regimen for allogeneic bone marrow transplantation for patients with acute leukemia

S. Jagannath, A. Zander, M. Keating, 1987, Cancer.

Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphoma.

L. North, A. Younes, F. Hagemeister, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels.

S. Tucker, W. Velasquez, P. Mclaughlin, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recent trends in the management of lymphomas at M.D. Anderson Cancer Center.

F. Cabanillas, M. Rodriguez, F. Swan, 1990, Seminars in oncology.

High rate of prolonged remissions following combined modality therapy for patients with localized low-grade lymphoma.

L. Fuller, F. Cabanillas, J. Cox, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Growth inhibition of follicular small-cleaved-cell lymphoma cells in short-term culture by interleukin-3.

F. Cabanillas, A. Younes, A. Sarris, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).

S. Jagannath, S. Tucker, W. Velasquez, 1988, Blood.

Relationship between DNA ploidy level, nuclear size, and survival in large cell lymphoma.

R. Kiss, I. Salmon, J. Pasteels, 1995, American journal of clinical pathology.

Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas.

F. Cabanillas, P. Allen, F. Hagemeister, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse.

W. Velasquez, L. Fuller, P. Mclaughlin, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma.

F. Cabanillas, S. Pathak, A. Cork, 1989, The American journal of medicine.

Prognostic role of serum beta 2-microglobulin in Hodgkin's disease.

L. Fuller, F. Cabanillas, P. Allen, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic Value of Serum β-2 Microglobulin in Low-Grade Lymphoma

S. Tucker, W. Velasquez, P. Mclaughlin, 1991 .

Original article: Two cycles of MOPP and radiotherapy: Effective treatment for stage IIIA and IIIB Hodgkin's disease

W. Velasquez, L. Fuller, P. Mclaughlin, 1991 .

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.

P. Mclaughlin, F. Cabanillas, M. Keating, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stage I-II low-grade lymphomas: a prospective trial of combination chemotherapy and radiotherapy.

W. Velasquez, L. Fuller, P. Mclaughlin, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.

S. Tucker, W. Velasquez, P. Mclaughlin, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Therapy of relapsed or refractory low-grade follicular lymphomas: factors associated with complete remission, survival and time to treatment failure.

W. Velasquez, P. Mclaughlin, F. Cabanillas, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation.

W. Velasquez, L. Fuller, P. Mclaughlin, 1995, International journal of radiation oncology, biology, physics.

A randomized, placebo-controlled phase ii study evaluating the reduction of neutropenia and febrile neutropenia in patients with colorectal cancer receiving pegfilgrastim with every-2-week chemotherapy.

J. Hecht, J. Hecht, W. Heim, 2010, Clinical colorectal cancer.

A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the 'tumor score'.

P. Mclaughlin, F. Cabanillas, F. Hagemeister, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP.

W. Velasquez, P. Mclaughlin, F. Cabanillas, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas.

W. Velasquez, P. Mclaughlin, F. Cabanillas, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy.

D. Podoloff, F. Cabanillas, F. Hagemeister, 1994, Annals of Oncology.

Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase.

S. Tucker, W. Velasquez, P. Mclaughlin, 1995, Leukemia & lymphoma.

Risk classification as the basis for clinical staging of diffuse large-cell lymphoma derived from 10-year survival data.

S. Jagannath, S. Tucker, W. Velasquez, 1989, Blood.

Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapy.

S. Jagannath, S. Tucker, W. Velasquez, 1991, Blood.

Small noncleaved cell lymphoma in adults: superior results for stages I-III disease.

S. Tucker, W. Velasquez, P. Mclaughlin, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS ASHAP: A Regimen for Cytoreduction of Refractory or Recurrent Hodgkin's Disease

P. Mclaughlin, F. Cabanillas, B. Andersson, 2016 .

ASHAP: a regimen for cytoreduction of refractory or recurrent Hodgkin's disease.

P. Mclaughlin, F. Cabanillas, B. Andersson, 1999, Blood.

A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas

P. Mclaughlin, F. Cabanillas, A. Younes, 1994, Investigational New Drugs.

Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease.

S. Jagannath, W. Velasquez, P. Mclaughlin, 1988, Seminars in hematology.

Intermediate‐grade lymphomas treated with cyclophosphamide‐doxorubicin‐vincristine‐prednisone‐bleomycin alternated with cyclophosphamide‐methotrexate‐etoposide‐dexamethasone. Application of prognostic models to data analysis

S. Tucker, W. Velasquez, L. Fuller, 1994, Cancer.

CHOP-Bleo plus interferon for stage IV low-grade lymphoma.

W. Velasquez, P. Mclaughlin, F. Cabanillas, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase.

F. Cabanillas, F. Cabanillas, R. Luthra, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.

F. Cabanillas, J. Cox, P. Allen, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.

L. Fuller, P. Mclaughlin, F. Cabanillas, 1994, Seminars in hematology.

J. Hecht, W. Heim, M. Mo, 2010, Clinical colorectal cancer.

NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease.

W. Velasquez, F. Cabanillas, M. Meistrich, 1990, Seminars in oncology.